196 related articles for article (PubMed ID: 31117243)
1. Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene.
Wang Q; Mehmood A; Wang H; Xu Q; Xiong Y; Wei DQ
Molecules; 2019 May; 24(10):. PubMed ID: 31117243
[TBL] [Abstract][Full Text] [Related]
2. [In silico study of a functional mutation associated with non-small cell lung cancer: G12D mutation of exon 2 in KRAS gene].
Bouras N; Bousahba A; Megaïz A; de Fraipont F; Sahraoui T; Kebir FZE
Ann Biol Clin (Paris); 2019 Jun; 77(3):287-294. PubMed ID: 31021322
[TBL] [Abstract][Full Text] [Related]
3. In silico analysis and high-risk pathogenic phenotype predictions of non-synonymous single nucleotide polymorphisms in human Crystallin beta A4 gene associated with congenital cataract.
Wang Z; Huang C; Lv H; Zhang M; Li X
PLoS One; 2020; 15(1):e0227859. PubMed ID: 31935276
[TBL] [Abstract][Full Text] [Related]
4. EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
Sahnane N; Frattini M; Bernasconi B; Zappa F; Schiavone G; Wannesson L; Antonelli P; Balzarini P; Sessa F; Mazzucchelli L; Tibiletti MG; Martin V
Clin Lung Cancer; 2016 Jan; 17(1):56-61. PubMed ID: 26381283
[TBL] [Abstract][Full Text] [Related]
5. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
6. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.
Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA
Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445
[TBL] [Abstract][Full Text] [Related]
7. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human
Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831
[TBL] [Abstract][Full Text] [Related]
8. Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications.
Ricciuti B; Leonardi GC; Metro G; Grignani F; Paglialunga L; Bellezza G; Baglivo S; Mencaroni C; Baldi A; Zicari D; Crinò L
Expert Rev Respir Med; 2016; 10(1):53-68. PubMed ID: 26714748
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor and v-Ki-ras2 Kirsten rat sarcoma viral oncogen homologue-specific amino acid substitutions are associated with different histopathological prognostic factors in resected non-small-cell lung cancer.
Seitlinger J; Renaud S; Falcoz PE; Schaeffer M; Olland A; Reeb J; Santelmo N; Legrain M; Voegeli AC; Weingertner N; Chenard MP; Beau-Faller M; Massard G
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):902-907. PubMed ID: 27530493
[TBL] [Abstract][Full Text] [Related]
10. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations.
Song DH; Lee B; Shin Y; Choi IH; Ha SY; Lee JJ; Hong ME; Choi YL; Han J; Um SW
Diagn Cytopathol; 2015 Jul; 43(7):539-44. PubMed ID: 25427298
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
Sánchez-Font A; Chalela R; Martín-Ontiyuelo C; Albero-González R; Dalmases A; Longarón R; Alonso-Espinaco V; Curull V; Bellosillo B; Pijuan L
Cancer Cytopathol; 2018 Oct; 126(10):860-871. PubMed ID: 30291816
[TBL] [Abstract][Full Text] [Related]
12. Computational analysis of non-synonymous single nucleotide polymorphism in the bovine
Hoda A; Bixheku X; Lika Çekani M
J Biomol Struct Dyn; 2024 May; 42(8):4155-4168. PubMed ID: 37278385
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy.
van der Drift MA; Prinsen CFM; Knuiman GJ; Janssen JP; Dekhuijzen PNR; Thunnissen FBJM
Chest; 2012 Jan; 141(1):169-175. PubMed ID: 21700687
[TBL] [Abstract][Full Text] [Related]
14. The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.
He XP; Song FJ; Liu XY; Wang Z; Li XX; Liu FY; Chen G; Jiang WP
J Int Med Res; 2013 Oct; 41(5):1473-83. PubMed ID: 23975858
[TBL] [Abstract][Full Text] [Related]
15. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
16. Identification and structural characterization of deleterious non-synonymous single nucleotide polymorphisms in the human SKP2 gene.
Hosen SMZ; Dash R; Junaid M; Mitra S; Absar N
Comput Biol Chem; 2019 Apr; 79():127-136. PubMed ID: 30802828
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases.
Renaud S; Falcoz PE; Schaëffer M; Guenot D; Romain B; Olland A; Reeb J; Santelmo N; Chenard MP; Legrain M; Voegeli AC; Beau-Faller M; Massard G
Br J Cancer; 2015 Oct; 113(8):1206-15. PubMed ID: 26372703
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.
Okamoto T; Kohno M; Ito K; Takada K; Katsura M; Morodomi Y; Toyokawa G; Shoji F; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1729-1735. PubMed ID: 28373435
[TBL] [Abstract][Full Text] [Related]
19. In silico analysis of Single Nucleotide Polymorphisms (SNPs) in human BRAF gene.
Hussain MR; Shaik NA; Al-Aama JY; Asfour HZ; Khan FS; Masoodi TA; Khan MA; Shaik NS
Gene; 2012 Oct; 508(2):188-96. PubMed ID: 22824468
[TBL] [Abstract][Full Text] [Related]
20. Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Lococo F; Gandolfi G; Rossi G; Pinto C; Rapicetta C; Cavazza A; Cesario A; Galeone C; Paci M; Ciarrocchi A
J Thorac Oncol; 2016 Aug; 11(8):1282-1292. PubMed ID: 27156442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
